A carregar...
SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end‐joining
BACKGROUND: DNA double‐strand breaks (DSBs) are harmful to the cell as it could lead to genomic instability and cell death when left unrepaired. Homologous recombination and nonhomologous end‐joining (NHEJ) are two major DSB repair pathways, responsible for ensuring genome integrity in mammals. Ther...
Na minha lista:
| Publicado no: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8222562/ https://ncbi.nlm.nih.gov/pubmed/33496064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1341 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|